Literature DB >> 19336924

Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.

Takafumi Okura1, Jitsuo Higaki, Mie Kurata, Jun Irita, Ken-ichi Miyoshi, Tsutomu Yamazaki, Doubun Hayashi, Takahide Kohro, Ryozo Nagai.   

Abstract

BACKGROUND: The association of elevated serum uric acid (UA) with cardiovascular events in patients with severe coronary artery stenosis was examined. METHODS AND
RESULTS: Patients with stenosis > or = 75% (n=8,832) were followed for "all events" (cardiovascular events and all-cause mortality) for 3 years. The group was divided into quartiles based on baseline UA level. The incidence rate of all events was significantly different among quartiles (58.3, 56.5, 61.2, 76.3/1,000 patients-year, P<0.001). Cox's proportional hazard regression analysis showed that the hazard ratio (HR) for all events was 1.25 [95% confidence interval (CI): 1.07-1.45, P<0.01] in the highest quartile (UA > or = 6.8 mg/dl). The group in which UA increased > or = 1.0 mg/dl after 6 months had significantly higher cardiovascular events rate than the group in which UA did not change (70.6 vs 58.8/1,000 patients-year, P=0.042). Propensity score matching was performed and 4,206 patients were divided into the highest quartile and the rest. High UA remained an independent predictor of all events (HR 1.25, 95%CI 1.06-1.43). However, no significant difference was observed between the group with increased UA > or = 1.0 mg/dl and the group with unchanged UA level.
CONCLUSIONS: Elevated UA is an independent predictor of cardiovascular events and all-cause mortality combined in patients with coronary artery stenosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336924     DOI: 10.1253/circj.cj-08-0828

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  18 in total

1.  Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease.

Authors:  Xiao-Min Dai; Lei Wei; Li-Li Ma; Hui-Yong Chen; Zhuo-Jun Zhang; Zong-Fei Ji; Wan-Long Wu; Ling-Ying Ma; Xiu-Fang Kong; Lin-Di Jiang
Journal:  Clin Rheumatol       Date:  2015-01-29       Impact factor: 2.980

2.  Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography.

Authors:  Rada Gancheva; Atanas Kundurdjiev; Mariana Ivanova; Todor Kundurzhiev; Zlatimir Kolarov
Journal:  Rheumatol Int       Date:  2016-08-30       Impact factor: 2.631

Review 3.  Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

Authors:  Ankoor Shah; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

4.  Potential role of uric Acid as a risk factor for cardiovascular disease.

Authors:  Duk-Hee Kang
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 2.884

Review 5.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

Review 6.  Uric acid transport and disease.

Authors:  Alexander So; Bernard Thorens
Journal:  J Clin Invest       Date:  2010-06-01       Impact factor: 14.808

Review 7.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 8.  Hyperuricemia, Cardiovascular Disease, and Hypertension.

Authors:  Masanari Kuwabara
Journal:  Pulse (Basel)       Date:  2016-03-12

9.  Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease.

Authors:  Altan Onat; Günay Can; Ender Örnek; Servet Altay; Murat Yüksel; Evin Ademoğlu
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

10.  Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3.

Authors:  Philip D Evans; Natasha J McIntyre; Richard J Fluck; Christopher W McIntyre; Maarten W Taal
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.